Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adaptative, Multicenter, Randomized, Double-blind, Parallel-group, Placebo Controlled, Clinical Trial, on the Efficacy and Tolerability of Different Escalating Doses of Intra-articular Clodronate in Patients With Painful Knee Osteoarthritis

NCT06263517 is registered in ClinicalTrials.gov with SPA Società Prodotti Antibiotici S.p.A. as lead sponsor.

NCT NCT06263517
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06263517 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adaptative, Multicenter, Randomized, Double-blind, Parallel-group, Placebo Controlled, Clinical Trial, on the Efficacy and Tolerability of Different Escalating Doses of Intra-articular Clodronate in Patients With Painful Knee Osteoarthritis
Lead sponsor
SPA Società Prodotti Antibiotici S.p.A.
Phase
Phase 2/3
Overall status
Unknown status
Start date
October 12, 2023
Completion date
October 31, 2025
Enrollment
296 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis of knee